According to a recent report by Future Market Insights, the market for treating rare neurological diseases will experience phenomenal growth between 2022 and 2032. By the end of 2032, revenues from the treatment of rare neurological disorders are expected to surpass US$ 19.795.14 million.According to a newly publish.
The immunoassay market is expected to observe growth at a CAGR of 5% and is anticipated to touch a valuation of USD 45.78 bn by 2032, while it holds a revenue of USD 29.51 Bn in 2022The dynamic shift from the last forecast period (2017-2021) to the current forecast period (2022-2032) is significant. The major factor.
[266 Pages Report] As per the latest market study by Future Market Insights (FMI), the global self-testing market is projected to record a CAGR of 5.6% amid the forecast period, 2022-2030.Self-testing Market Size (2022)US$ 7.49 BnRevenue Forecast (2030)US$ 11.55 BnGlobal Market Growth Rate (2022-2030)5.6% CAGRDomin.
Portable Bioprocessing Bioreactors Market is anticipated to be valued at US$ 6978.3 Mn by 2032 and is expected to grow at a CAGR of 14.6% from 2022 &n